NEU-627

N/A

Report date: 2025/04/20 20:00:03
NME

Base Information

Drug NameNEU-627
Drug Alias NameNEU-627
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase 2 inhibitors
TargetsTyrosine-protein kinase 2
Therapy Area/IndicationsNeuritisMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNew Zealand
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNeuron23 Inc
China Registration ClassN/A

Develop Information

Active CompaniesNeuron23 Inc
Inactive CompaniesN/A
Active IndicationsNeuritisMultiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A